SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-110189
Filing Date
2008-05-12
Accepted
2008-05-09 20:21:24
Documents
9
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 662468
2 FIFTH AMENDMENT TO THE AMGEN SUPPLEMENTAL RETIREMENT PLAN dex1015.htm EX-10.15 2844
3 AMENDED AND RESTATED AMGEN INC. PERFORMANCE AWARD PROGRAM dex1035.htm EX-10.35 57440
4 MULTI-PRODUCT LICENSE AGREEMENT WITH RESPECT TO JAPAN dex1082.htm EX-10.82 334725
5 LICENSE AGREEMENT FOR MOTESANIB DIPHOSPHATE dex1083.htm EX-10.83 341196
6 SUPPLY AGREEMENT dex1084.htm EX-10.84 175537
7 SALE AND PURCHASE AGREEMENT dex1085.htm EX-10.85 225393
8 SECTION 302 CERTIFICATIONS dex31.htm EX-31 20365
9 SECTION 906 CERTIFICATIONS dex32.htm EX-32 9025
  Complete submission text file 0001193125-08-110189.txt   1830520
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12477 | Film No.: 08820331
SIC: 2836 Biological Products, (No Diagnostic Substances)